The Bone Marrow Biopsy Market plays a pivotal role in diagnosing various hematological and oncological conditions. Recent innovations in this field include minimally invasive techniques, such as aspiration biopsies, reducing patient discomfort. Advanced imaging technologies, such as ultrasound and fluoroscopy, enhance the precision of the procedure. Additionally, the incorporation of molecular and genetic profiling has improved disease characterization, aiding in personalized treatment strategies. These innovations collectively enhance the diagnostic accuracy, patient experience, and effectiveness of bone marrow biopsies in managing complex medical conditions.
Access Full Report @ https://www.databridgemarketresearch.com/es/reports/asia-pacific-bone-marrow-biopsy-market
Data Bridge Market Research analyses that the Asia-Pacific Bone Marrow Biopsy Market value is USD 36.794 million in 2022, is expected to reach USD 60.878 million by 2030, at a CAGR of 6.1% during the forecast period 2023 to 2030. As the global cancer patient population rises, the demand for bone marrow biopsies increases. These procedures aid in diagnosing hematological malignancies and are crucial for treatment decisions, contributing to the higher demand for this diagnostic tool.
Key Findings of the Study
Aging population is expected to drive the market's growth rate
The aging population is more susceptible to hematological disorders such as leukemia, lymphoma, and myeloma. Hematological disorders often manifest with age-related changes in the bone marrow. Consequently, the demographic shift towards an older population has intensified the demand for diagnostic procedures such as bone marrow biopsies. These tests are crucial for identifying and characterizing these conditions, enabling timely treatment and care for the elderly, further fueling the need for diagnostic assessments in this age group.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Needles, Instruments, Biopsy Gun, Procedure Trays, Others), Procedure Type (Hip Biopsy, Breastbone (Sternum) Biopsy, Percutaneous Trephine Biopsy, Tibia (Shin) Biopsy, Others), Biopsy Type (Core Needle Biopsy, Vacuum-Assisted Biopsy (VAB), Fine Needle Aspiration Biopsy), Site (Posterior Iliac Crest, Anterior Iliac Crest, Calcaneus, Distal Tibia, Proximal Tibia, Proximal Humerus, Others), Technique (Flow Cytometry, Fluorescence In Situ Hybridization (Fish), Polymerase Chain Reaction (PCR), Karyotype Test, Other), Age (Geriatric, Adult, Pediatric), Application (Lymphoma Disease, Leukemia, Polycythemia Vera, Multiple Myeloma, Thrombocythemia, Myelofibrosis, Aplastic Anemia, Others), End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Academic and Research Organizations, Others), Distribution Channel (Direct Tender, Retail Sales)
|
|
Countries Covered
|
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
|
|
Market Players Covered
|
BD (U.S.), Medtronic (Ireland), ARGON MEDICAL (U.S.), Merit Medical Systems (U.S.), Cardinal Health (U.S.), Teleflex Incorporated (U.S.), Biomedical Srl (Italy), BPB MEDICA (Italy), Egemen International (Turkey), hiprove (China), MDL SRL (Italy), SOMATEX Medical Technologies GmbH (Germany), STERYLAB S.r.l. (Italy), Tsunami Medical (Italy), weLLgo Medical Products GmbH (Germany), Zamar Care (U.S.)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The Asia-Pacific bone marrow biopsy market is segmented on the basis of product type, procedure type, biopsy type, site, technique, age, application, end user and distribution channel.
- On the basis of product type, the Asia-Pacific bone marrow biopsy market is segmented into needles, instruments, biopsy gun, procedure trays, and others.
- On the basis of procedure type, the Asia-Pacific bone marrow biopsy market is segmented into hip biopsy, breastbone (sternum) biopsy, percutaneous trephine biopsy, tibia (shin) biopsy, and others.
- On the basis of biopsy type, the Asia-Pacific bone marrow biopsy market is segmented into core needle biopsy, vacuum-assisted biopsy (VAB), and fine needle aspiration biopsy.
- On the basis of site, the Asia-Pacific bone marrow biopsy market is segmented into posterior iliac crest, anterior iliac crest, calcaneus, distal tibia, proximal tibia, proximal humerus, and others.
- On the basis of technique, the Asia-Pacific bone marrow biopsy market is segmented into flow cytometry, fluorescence in situ hybridization (Fish), polymerase chain reaction (PCR), karyotype test, and other.
- On the basis of age, the Asia-Pacific bone marrow biopsy market is segmented into geriatric, adult, and pediatric.
- On the basis of application, the Asia-Pacific bone marrow biopsy market is segmented into lymphoma disease, leukemia, polycythemia vera, multiple myeloma, thrombocythemia, myelofibrosis, aplastic anemia, and others.
- On the basis of end user, the Asia-Pacific bone marrow biopsy market is segmented into hospitals, diagnostic centers, ambulatory surgical centers, academic and research organizations, and others.
- On the basis of distribution channel, the Asia-Pacific bone marrow biopsy market is segmented into direct tender, and retail sales.
Major Players
Data Bridge Market Research recognizes the following companies as the Asia-Pacific bone marrow biopsy market players in Asia-Pacific bone marrow biopsy market are BD (U.S.), Medtronic (Ireland), ARGON MEDICAL (U.S.), Merit Medical Systems (U.S.), Cardinal Health (U.S.), Teleflex Incorporated (U.S.), Biomedical Srl (Italy).
Market Development
- In May 2022, Argon Medical formed a strategic partnership with Terumo India to expand their presence in the Indian medical market. This collaboration enables the distribution of a wide range of medical products, including guide wires, IVC (Inferior Vena Cava) devices, and biopsy needles for bone and soft tissues. Through this venture, the companies aim to enhance access to critical medical supplies and contribute to healthcare advancements in India.
Regional Analysis
Geographically, the countries covered in the Asia-Pacific bone marrow biopsy market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
As per Data Bridge Market Research analysis:
China is the dominant region in Asia-Pacific bone marrow biopsy market during the forecast period 2023-2030
China dominates the Asia-Pacific bone marrow biopsy market, attributed to its rapidly increasing geriatric population. As the elderly demographic expands, there's a heightened demand for diagnostic procedures such as bone marrow biopsies, often used in the assessment of various hematological and oncological conditions. This demographic shift has propelled China to the forefront of the market, underscoring the significance of these procedures in addressing age-related health concerns.
Japan is expected to dominate the Asia-Pacific bone marrow biopsy market in the forecast period 2023-2030
Japan is expected to dominate the bone marrow biopsy market maintains modest growth with a nominal CAGR, because of advanced healthcare infrastructure. In contrast, India is experiencing significant market share growth. This is largely attributed to the proactive initiatives led by major healthcare organizations and government entities, working to enhance healthcare access, promote advanced diagnostic procedures such as bone marrow biopsies, and improve overall patient care.
For more detailed information about the Asia-Pacific bone marrow biopsy market report, click here – https://www.databridgemarketresearch.com/es/reports/asia-pacific-bone-marrow-biopsy-market
